APPLICATION
ANDA090403
TYPE
ANDA
ORIGINAL APPROVAL
2010-11-15
LATEST ACTION
2024-11-21
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription
Products
INDOMETHACINPrescription
INDOMETHACIN 50MG · CAPSULE · ORAL
INDOMETHACINPrescription
INDOMETHACIN 25MG · CAPSULE · ORAL
Approval history
2024-11-21Labeling · Supplement 8 · standardAP
2024-03-09Labeling · Supplement 7 · standardAP
2021-04-28Labeling · Supplement 6 · standardAP
2019-09-18Labeling · Supplement 5 · standardAP
2019-09-18Labeling · Supplement 3 · standardAP
2016-05-09Labeling · Supplement 1 · standardAP
2010-11-15OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.